Thrombotic Thrombocytopenic Purpura Clinical Trial
Official title:
An Observational Study of All Forms of Thrombotic Microangiopathy in Pediatric Patients
This registry will collect clinical data and store biosamples (seru, plasma, urine, and DNA) annually from pediatric patients with thrombotic mcroangiopathy
Children age, 6 months - 18 years, are eligible if they have one of the following categories
of thrombotic microangiopathy (TMA):(1) severe D+HUS; (2) non-familial atypical HUS; (3)
familial atypical HUS; or (4) TTP
Patients are seen intially and annually thereafter
Biosamples are collected for storage annually.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Recruiting |
NCT05785468 -
A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)
|
||
Completed |
NCT04074187 -
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
|
Phase 2/Phase 3 | |
Terminated |
NCT00953771 -
Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
|
Phase 2 | |
Recruiting |
NCT01257269 -
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
|
||
Not yet recruiting |
NCT05568147 -
Aspirin for Prophylaxis of TTP
|
Phase 2/Phase 3 | |
Recruiting |
NCT05468320 -
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
|
Phase 3 | |
Completed |
NCT00713193 -
Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
|
Phase 3 | |
Completed |
NCT00426686 -
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
|
N/A | |
Withdrawn |
NCT00251277 -
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
|
Phase 1/Phase 2 | |
Recruiting |
NCT04588194 -
Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
|
Phase 2 | |
Active, not recruiting |
NCT03237819 -
Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care
|
Phase 3 | |
Completed |
NCT00907751 -
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
|
Phase 2 | |
Completed |
NCT03369314 -
Observational Study of the Use of octaplasLG®.
|
||
Terminated |
NCT01938404 -
Octaplas Adult TTP Trial
|
||
Recruiting |
NCT04981028 -
The ConNeCT Study: Neurological Complications of TTP
|
||
Completed |
NCT02134171 -
Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
|
N/A | |
Recruiting |
NCT05389007 -
.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
|
||
Withdrawn |
NCT02626663 -
The Role of Microparticles as a Biomarker
|
||
Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|